Similar articles

• New approach to management of malignant ascites with a streptococcal preparation, OK-432. I. Improvement of host immunity and prolongation of survival.

  Torisu M, Katano M, Kimura Y, Itoh H, Takesue M. Torisu M, et al. Surgery. 1983 Mar;93(3):357-64. Surgery. 1983. PMID: 6187080 Clinical Trial. No abstract available.
• Efficacy of streptococcal preparation OK-432 for gastric cancer patients--comparison between intradermal and intramuscular injection.

  Hanaue H, Kurosawa T, Yoshizaki S, Shikata J. Hanaue H, et al. Jpn J Surg. 1984 May;14(3):191-7. doi: 10.1007/BF02469567. Jpn J Surg. 1984. PMID: 6611437
• [Su-polysaccharide skin test and immunotherapy with OK-432 in postoperative gastric cancer--the effect of a splenectomy].

  Saito H, Kikkawa H, Bando H, Sakatoku M, Hirano M, Tatsuzawa T. Saito H, et al. Gan No Rinsho. 1988 Nov;34(14):1965-8. Gan No Rinsho. 1988. PMID: 3204664 Japanese.
• [Postoperative cell-mediated immunity in gastric cancer patients--with special reference to the effects of immunotherapy].

  Sekizuka H, Noro K, Haruyama S, Kiribuchi Y, Hayashi F. Sekizuka H, et al. Gan No Rinsho. 1985 Sep;31(11):1381-6. Gan No Rinsho. 1985. PMID: 3877822 Japanese.
• [Immunotherapy of gastric cancer].

  Kan N, Ohgaki K, Okino T, Nakanishi M, Nio Y, Inoue K, Tobe T. Kan N, et al. Gan To Kagaku Ryoho. 1988 Apr;15(4 Pt 2-1):755-62. Gan To Kagaku Ryoho. 1988. PMID: 3291771 Review. Japanese.